Calyxt announced that its high-fiber wheat product has been designated a non-regulated article by the U.S. Department of Agriculture.
Once this product goes to market, a single serving of Calyxt’s high-fiber flour may provide the recommended daily requirement of fiber, the company said in announcing the news. Additionally, the product is now part of a total of seven Calyxt products that have been deemed non-regulated by USDA, including powdery mildew resistant wheat, high-oleic soybeans, high-oleic/low-linolenic soybeans, improved-quality alfalfa, cold storable potato and reduced-browning potato.
This is a key step in the product’s path to commercialization and in furthering Calyxt’s goal of putting more great-tasting, plant-based ingredients with healthier characteristics on consumers’ plates, the company said. Calyxt still plans for the commercialization of its high-oleic soybean product by the end of 2018.
Calyxt, an agriculturally based company developing a pipeline of genetically "improved" crops that it believes will satisfy consumer demand for "healthier" versions, went public July 20 and began trading on the Nasdaq market under the ticker CLXT.
The New Brighton, Minn.-based company, founded in 2010 as the agricultural biotechnology unit of gene editing company Cellectis S.A., is focused on developing genetically improved crops across a range of crop types. Cellectis, based in Paris, France, is a clinical-stage biopharmaceutical company that harnesses the immune system to target and eradicate cancer cells.